Novartis says Lu-PSMA-617 therapy imp... - Advanced Prostate...
Novartis says Lu-PSMA-617 therapy improves Prostate Cancer Survival
Written by
dexy1234
To view profiles and participate in discussions please or .
2 Replies
•
Sounds good but I wish they didn’t makes us wait for their findings.
Thanks for sharing ....
Not what you're looking for?
You may also like...
225Ac-PSMA-617/177Lu-PSMA-617 tandem therapy of metastatic castration-resistant prostate cancer
tandem theraphy is available somewhere in Europe?
https://pubmed.ncbi.nlm.nih.gov/31758224/...
EXPANDED ACCESS FOR Lu-PSMA-617
patient with metastatic castration-resistant prostate cancer access to an investigative medical...
Short update on Lu-617 therapy
Well, now 9 days after 1st Lu-617 therapy. Some fatigue persists. No other side effects. Bone pain...
Opinions on Lu-PSMA-617 Clinical Trial
now for his metastatic castration resistant prostate cancer (metastasized to the coccyx/pelvic bone...
VISION trial results of Lu-177-PSMA-617
phase-iii-study-radioligand-therapy-177lu-psma-617-patients-advanced-prostate-cancer
PSMA PET required for LU PSMA therapy?
Update on my fathers 1st Lu-177-PSMA-617 treatment 
Lutetium-177 PSMA-617 (LuPSMA) therapy
